AMAG Pharmaceuticals, Inc. to Participate in the Cowen and Company 35th Annual Healthcare Conference

AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that William Heiden, AMAG's president and chief executive officer, will present at the Cowen and Company 35th Annual Healthcare Conference on Monday, March 2, 2015 at 2:10 p.m. ET in Boston. The session will include a company presentation followed by a question and answer session, in which the company's financial results, business update, regulatory status, and growth prospects will be discussed.

A live webcast of the presentation will be accessible through the Investors section of the company's website at www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for 30 days.

About AMAG

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company with a focus on maternal health, anemia and cancer supportive care. The primary goal of AMAG is to bring to market therapies that provide clear benefits and improve patients' lives. In addition to continuing to pursue opportunities to make new advancements in patients' health and to enhance treatment accessibility, AMAG intends to continue to expand and diversify its portfolio through the in-license or purchase of additional pharmaceutical products or companies. For additional company information, please visit www.amagpharma.com.

CONTACT: AMAG Pharmaceuticals, Inc.
         Katie Payne, 617-498-3303